Medicaid Payments For Cell, Gene Therapies Outside Hospital Bundle Supported By Developers

Separate, and higher, payments outside the bundle means manufacturers will owe Medicaid rebates, and that is OK, Alliance for Regenerative Medicine tells Sen. Cassidy. But manufacturers want assurances they won't be liable for rebates on treatments included in bundled payments.

Bundled Payments More Typical For Cell and Gene Therapies In Medicaid • Source: Shutterstock

More from Market Access

More from Pink Sheet